Inhibition of HIF-1α by Atorvastatin During 131I-RTX Therapy in Burkitt's Lymphoma Model.

Eun Ho KimHae Young KoA Ram YuHyeongi KimJaveria ZaheerHyun Ji KangYoung-Cheol LimKyung Deuk ChoHyun-Yoo JooMin Kyoung KangJae Jun LeeSeung-Sook LeeHye Jin KangSang Moo LimHyeongi Kim

Published in: Cancers (2020)

Our findings suggested that combination therapy with ATV and 131I-RTX is a promising strategy for enhancing the potency of 131I-RTX therapy in poorly responding patients and those with radio-resistance.

Keyphrases

combination therapy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
diffuse large b cell lymphoma
cell therapy
replacement therapy
smoking cessation